Minerva Imaging will attend the EANM congress, October 12-16 2019, Barcelona, Spain.

Minerva Imaging is working with preclinical disease models in oncology and cardiovascular disease. We are specialised in nuclear medicine and have a strong track record in targeted radionuclide therapy and translational imaging studies. 

If you are interested in learning more about our services or set up a meeting during the congress, please contact us co-founder and CEO, Carsten H. Nielsen or co-founder and CSO, Andreas Kjaer.

Schedule a meeting with us